{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:29:05Z","timestamp":1790342945244,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.10874","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T19:52:42Z","timestamp":1595015562000},"page":"e2010874","source":"Crossref","is-referenced-by-count":58,"title":["Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease"],"prefix":"10.1001","volume":"3","author":[{"given":"Donald I.","family":"Abrams","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Couey","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Dixit","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sagi","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology-Oncology-Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ward","family":"Hagar","sequence":"additional","affiliation":[{"name":"UCSF Benioff Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"UCSF Benioff Children\u2019s Hospital Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Kelly","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Connett","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"Vascular Biology Center, Division of Hematology-Oncology-Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis"},{"name":"Hemtology\/Oncology Division, Department of Medicine, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"zoi200426r2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.socscimed.2019.06.005","article-title":"Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis.","volume":"233","author":"Kosiba","year":"2019","journal-title":"Soc Sci Med"},{"issue":"3","key":"zoi200426r4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease.","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi200426r5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease.","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi200426r6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease.","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi200426r7","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/pm\/pnw074","article-title":"The opioid drug epidemic and sickle cell disease: guilt by association.","volume":"17","author":"Ruta","year":"2016","journal-title":"Pain Med"},{"issue":"9","key":"zoi200426r8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: a systematic review of the literature.","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"zoi200426r9","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1182\/blood-2017-05-782003","article-title":"Targeting novel mechanisms of pain in sickle cell disease.","volume":"130","author":"Tran","year":"2017","journal-title":"Blood"},{"issue":"3","key":"zoi200426r10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"5","key":"zoi200426r11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3324\/haematol.2015.136523","article-title":"Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.","volume":"101","author":"Vincent","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"zoi200426r12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/bjh.2012.156.issue-4","article-title":"Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.","volume":"156","author":"Cain","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"zoi200426r13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5055\/jom.2009.0034","article-title":"The analgesic potential of cannabinoids.","volume":"5","author":"Elikkottil","year":"2009","journal-title":"J Opioid Manag"},{"issue":"7","key":"zoi200426r14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","article-title":"Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.","volume":"68","author":"Abrams","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"zoi200426r15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data.","volume":"16","author":"Andreae","year":"2015","journal-title":"J Pain"},{"issue":"S1","key":"zoi200426r16","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/jcph.2002.42.issue-S1","article-title":"Cannabidiol: an overview of some pharmacological aspects.","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"zoi200426r17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/phar.1780","article-title":"Current status and prospects for cannabidiol preparations as new therapeutic agents.","volume":"36","author":"Fasinu","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"5","key":"zoi200426r18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/sj.clpt.6100200","article-title":"Vaporization as a smokeless cannabis delivery system: a pilot study.","volume":"82","author":"Abrams","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200426r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0195-6663(88)80017-5","article-title":"Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.","volume":"11","author":"Foltin","year":"1988","journal-title":"Appetite"},{"issue":"2","key":"zoi200426r20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the Brief Pain Inventory for chronic nonmalignant pain.","volume":"5","author":"Tan","year":"2004","journal-title":"J Pain"},{"issue":"9","key":"zoi200426r22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1182\/blood-2018-11-876839","article-title":"Bad weed: synthetic cannabinoid-associated coagulopathy.","volume":"133","author":"Arepally","year":"2019","journal-title":"Blood"},{"issue":"4","key":"zoi200426r23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/S0043-31442006000400004","article-title":"The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study.","volume":"55","author":"Knight-Madden","year":"2006","journal-title":"West Indian Med J"},{"issue":"1","key":"zoi200426r24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bjh.2005.131.issue-1","article-title":"Cannabis use in sickle cell disease: a questionnaire study.","volume":"131","author":"Howard","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"zoi200426r25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/can.2017.0011","article-title":"The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occlusive crises.","volume":"2","author":"Ballas","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"zoi200426r26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1089\/can.2018.0001","article-title":"Marijuana use in adults living with sickle cell disease.","volume":"3","author":"Roberts","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"zoi200426r27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain.","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200426r28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man.","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"zoi200426r29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00406-019-00978-2","article-title":"A randomised controlled trial of vaporised ?9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.","volume":"269","author":"Solowij","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"zoi200426r30","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi200426r31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamainternmed.2018.0266","article-title":"Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population.","volume":"178","author":"Bradford","year":"2018","journal-title":"JAMA Intern Med"},{"key":"zoi200426r3","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, Engineering and Medicine","year":"2017"},{"key":"zoi200426r1","unstructured":"National Conference of State Legislatures. State medical marijuana laws. Accessed May 31, 2019. https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx"},{"key":"zoi200426r21","unstructured":"Centers for Disease Control and Prevention. CDC, FDA, states continue to investigate severe pulmonary disease among people who use e-cigarettes. Accessed June 15, 2020. https:\/\/www.cdc.gov\/media\/releases\/2019\/s0821-cdc-fda-states-e-cigarettes.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2768349\/abrams_2020_oi_200426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T19:52:47Z","timestamp":1595015567000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2768349"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.10874","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}